程亮毕业于北京医科大学(北京大学医学部), 后在美国Case Western Reserve University和Mayo Clinic接受专业病理训练现任美国印第安那大学医学院Virgil H. Moon讲席教授，分子诊断实验室主任，泌尿病理主任, 病理系及泌尿系终身教授。持有美国外科病理、临床病理和分子遗传医师执照。现任Molecular Cancer (Associate Editor), Hum Pathol (Senior Associate Editor), Future Oncology, Urol Oncol, Crit Rev Oncol Hematol, Am J Surg Patholoy, Mod Pathol, Eur J Cancer, J Pathol, Histopathology, J Clin Pathol等30多个杂志的编委，在影响因子较高的期刊,包括Nature Biotechnol,PNAS,JNCI,J Clin Oncol, Cell Metabolism, Cancer Res, J Pathol, Oncogene和Clin Cancer Res发表SCI学术论文720多篇, 被引用超过26,000多次(h-index,83)。主编和撰写的著作有Molecular Genetic Pathology, Molecular Surgical Pathology, Urologic Surgical Pathology, Essentials of Anatomic Pathology, Atlas of Genitourinary Pathology, Atlas of Anatomic Pathology (Series Editor),及Bladder Pathology。
Qualifications and experience:
Virgil H. Moon Professor of Pathology, Indiana University School of Medicine Chief of the Genitourinary Pathology Service Dr. Liang Cheng is Professor of Pathology and Urology at the Indiana University School of Medicine, Indianapolis, Indiana, USA. Currently, he is the Chief of the Genitourinary Pathology Service, Director of the Urologic Pathology Fellowship, and Director of Molecular Diagnostics and Molecular Pathology Laboratories. Dr. Cheng is board certified in Molecular Genetic Pathology and Anatomic and Clinical Pathology by the American Board of Pathology. Dr. Cheng graduated from Beijing Medical University, China. Dr. Cheng completed his pathology residency at Case Western Reserve University, Cleveland, Ohio and his fellowship at the Mayo Clinic, Rochester, Minnesota in 1998. Dr. Cheng has received numerous prestigious awards including the Stowell-Orbison Award from the United States and Canadian Academy of Pathology (USCAP) and the Koss Medal Award from the International Society of Urological Pathology (ISUP). In 2006, he was the Arthur Purdy Stout Prize recipient from the Arthur Purdy Stout Society of Surgical Pathologists in recognition of outstanding contributions to the field of surgical pathology for a surgical pathologist less than 45 years old. Dr. Cheng has published more than 600 peer-reviewed articles in high-impact scientific journals. His published work has been cited more than 18,000 times (i10-index, 362; h-index, 71. He established a record for the greatest number of abstract presentations (36) in the history of the United States and Canadian Academy of Pathology (USCAP), accounting for 2.3% (36/1551) of total abstracts accepted in the 2004 annual meeting in Vancouver. He was also the author of over 70 book chapters and several books. His Springer books include Essentials of Anatomic Pathology (Springer, 2002, 2006, 2011), Molecular Genetic Pathology (Springer, 2008 and 2013), Atlas of Genitourinary Pathology (Springer, 2011), Molecular Surgical Pathology (Springer, 2013), and Atlas of Anatomic Pathology (Series Editor, Springer, 2011-present). Dr. Cheng was the principal and co-investigator for >30 funded grants and have served as a member of over 30 Grant Review Panels for Federal Funding Agencies (NIH/NCI, SPORE, DOD etc). Currently, he is an active member of over 30 editorial boards, including Molecular Cancer (Associate editor), European Journal of Cancer, American Journal of Surgical Pathology, Modern Pathology, Human Pathology, Histopathology, Journal of Clinical Pathology, Future Oncology, Urologic Oncology, Expert Review of Anticancer Therapy, Critical Review Hematology Oncology. Dr. Cheng's research focuses on molecular genetics and biological predictors of genitourinary cancers. M.D. Beijing Medical University, China Resident in Pathology, Case Western Reserve University Fellow in Urologic Surgical Pathology, Mayo Clinic Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology Subspecialty Certification: Molecular Genetic Pathology Special Interest: Urologic pathology, Molecular diagnostics and Molecular genetic pathology